Drolsum Liv
Department of Ophthalmology, Ullevaal University Hospital, Oslo, Norway.
Acta Ophthalmol Scand. 2006 Aug;84(4):502-6. doi: 10.1111/j.1600-0420.2006.00674.x.
To compare the longterm results in pseudoexfoliative glaucoma and primary open-angle glaucoma (POAG) following deep sclerectomy with implant.
A total of 28 pseudoexfoliative glaucoma eyes and 27 POAG eyes were consecutively included in the study. Intraocular pressure (IOP) and number of glaucoma medications were compared before surgery and at every postoperative visit. Most patients included had very advanced glaucoma and were using multiple therapies (mean 3.3 and 3.6 in the pseudoexfoliative glaucoma and POAG groups, respectively) and the duration of the disease was more than 8 years in both groups. The definition of complete success was the achievement of IOP < 19 mmHg without therapy.
After a mean follow-up time of 45 months in the pseudoexfoliative glaucoma group and 43 months in the POAG group, 50.0% of the pseudoexfoliative glaucoma group were considered to represent complete success compared with 33.3% of the POAG group (NS). In survival analyses controlling for covariates, it was found that patients with pseudoexfoliative glaucoma had a higher rate of success over time than POAG patients (p = 0.014). Furthermore, the duration of glaucoma prior to surgery had a negative influence on the success rate (p = 0.034). Four years after surgery, the mean IOP was 15.5 +/- 5.3 mmHg in the pseudoexfoliative glaucoma group and 13.6 +/- 3.5 mmHg in the POAG group (NS). The mean number of medications used by each group at that time was 1.7 +/- 1.5 and 1.2 +/- 1.1, respectively (NS).
The present study suggests that deep sclerectomy is a safe procedure in pseudoexfoliative glaucoma. Half of the patients were regulated without therapy after 45 months.
比较植入物深层巩膜切除术治疗剥脱性青光眼和原发性开角型青光眼(POAG)的长期效果。
本研究连续纳入28只剥脱性青光眼患眼和27只POAG患眼。比较手术前及术后每次随访时的眼压(IOP)和青光眼药物使用数量。纳入的大多数患者青光眼病情非常严重,且正在使用多种治疗方法(剥脱性青光眼组和POAG组的平均治疗方法数分别为3.3种和3.6种),两组疾病持续时间均超过8年。完全成功的定义为无需治疗眼压<19 mmHg。
剥脱性青光眼组平均随访时间为45个月,POAG组为43个月,剥脱性青光眼组50.0%的患者被认为达到完全成功,而POAG组为33.3%(无显著性差异)。在控制协变量的生存分析中,发现剥脱性青光眼患者随时间推移的成功率高于POAG患者(p = 0.014)。此外,手术前青光眼的持续时间对成功率有负面影响(p = 0.034)。术后4年,剥脱性青光眼组的平均眼压为15.5±5.3 mmHg,POAG组为13.6±3.5 mmHg(无显著性差异)。此时每组使用的平均药物数量分别为1.7±1.5和1.2±1.1(无显著性差异)。
本研究表明,深层巩膜切除术治疗剥脱性青光眼是一种安全的手术方法。45个月后,一半的患者无需治疗眼压得到控制。